CNMD: CONMED Corporation Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 1,536.48
Enterprise Value ($M) 2,415.93
Book Value ($M) 932.90
Book Value / Share 30.18
Price / Book 1.65
NCAV ($M) -703.56
NCAV / Share -22.76
Price / NCAV -2.18

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.16

Liquidity (mrq)
Quick Ratio 1.05
Current Ratio 2.30

Balance Sheet (mrq) ($M)
Current Assets 640.01
Assets 2,306.25
Liabilities 1,343.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,307.02
Operating Income 167.56
Net Income 132.42
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 166.97
Cash from Investing -13.08
Cash from Financing -151.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-13 13G/A Earnest Partners Llc 9.00 18.70
11-12 13G/A Capital Research Global Investors 5.00 -43.98

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-18 10-K United States Securities and Exchange Commission Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-24 75,310 271,932 27.69
2025-04-23 136,869 529,591 25.84
2025-04-22 55,609 326,383 17.04
2025-04-21 130,843 453,367 28.86

(click for more detail)

Similar Companies
BFLY – Butterfly Network, Inc. BSX – Boston Scientific Corporation
CDRE – Cadre Holdings, Inc. ENOV – Enovis Corporation
EW – Edwards Lifesciences Corporation


Financial data and stock pages provided by
Fintel.io